ACE2 and infection: These features, together with the high RBD immunogenicity during human natural infection, vaccination and animal immunization, as well as the efficient neutralization of the RBD-ACE2 interaction by anti-RBD antibodies, encouraged the search for a smaller fragment with vaccine potential, suitable for production by peptide synthesis technology.